Minerva Neurosciences (NERV) Interest Coverage Ratio (2013 - 2026)
Minerva Neurosciences (NERV) posted Interest Coverage Ratio of 1.02 for Q1 2026, up 73.88% on a QoQ basis from 3.92 in Q4 2025.
Minerva Neurosciences (NERV) Interest Coverage Ratio (2013 - 2026) Analysis & Trends
Minerva Neurosciences' Interest Coverage Ratio history runs 14 years deep, the most recent figure standing at 1.02 for Q1 2026.
- Quarterly Interest Coverage Ratio changed N/A year-over-year to 1.02 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.71 (changed N/A YoY) and the FY2025 annual result came in at 0.15, up 33.38% from the prior year.
- Interest Coverage Ratio was 1.02 for Q1 2026 at Minerva Neurosciences, up from 3.92 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.06 in Q4 2022 and bottomed at 369.27 in Q2 2024.
- A 5-year average of 62.49 and a median of 4.89 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio sank 132678.24% — and 2025, when it soared 96.01%.
- Minerva Neurosciences' Interest Coverage Ratio stood at 0.06 in 2022, then slumped by 31.6% to 0.07 in 2023, then sank by 132678.24% to 98.31 in 2024, then soared by 96.01% to 3.92 in 2025, then surged by 73.88% to 1.02 in 2026.
- Business Quant data shows NERV's Interest Coverage Ratio at 1.02 in Q1 2026, 3.92 in Q4 2025, and 98.31 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Minerva Neurosciences | 195.10 Mn | 195.10 Mn | - | -1.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.02 |
| Dec 31, 2025 | -3.92 |
| Dec 31, 2024 | -98.31 |
| Jun 30, 2024 | -369.27 |
| Dec 31, 2023 | -0.07 |
| Sep 30, 2023 | -5.86 |
| Jun 30, 2023 | -2.24 |
| Dec 31, 2022 | -0.06 |
| Sep 30, 2022 | -8.24 |
| Mar 31, 2022 | -135.87 |
| Sep 30, 2021 | -37.61 |
| Jun 30, 2021 | -550.30 |
| Mar 31, 2021 | -115.23 |
| Dec 31, 2020 | -149.37 |
| Sep 30, 2020 | -49.67 |
| Jun 30, 2020 | 139.68 |
| Mar 31, 2020 | -7.55 |
| Dec 31, 2019 | -683.08 |
| Sep 30, 2019 | -1.30 |
| Jun 30, 2019 | -13.66 |